MedTrace Logo

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

NCT03426397 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2020-07-29

No results posted yet for this study

Summary

The aim of this prospective observational cohort study is to provide short and long term oncological and functional outcome data on organ preserving treatment in good responders after a standard indication for neoadjuvant (chemo)radiation for rectal cancer.

Conditions

  • Rectal Neoplasms

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • The Netherlands Cancer Institute

    lead OTHER

Principal Investigators

  • Geerard Beets, MD, PhD · Antoni van Leeuwenhoek - Netherlands Cancer Institute

  • Regina Beets -Tan, MD, PhD · Antoni van Leeuwenhoek - Netherlands Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2021-06-01
Completion
2026-06-01

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03426397 on ClinicalTrials.gov